# Versatope Therapeutics Inc.

Canonical: https://abierto.us/vendors/versatope-therapeutics-inc-vsmpm3egyya6

- UEI: VSMPM3EGYYA6
- CAGE: 7TEE7
- Location: Lowell, MA
- Awards in window: 1 (8 transactions), $4,563,592 obligated, January 31, 2024 to May 29, 2025

## Awarding agencies

- National Institutes of Health: 1 awards, $4,563,592

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $4,563,592

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75N93019C00060 (definitive contract): $4,563,592, National Institutes of Health Niaid. To Advance the Lead Universal Influenza Vaccine Candidate Through a Phase I Clinical Study and to Evaluate the Long-Term Immunogenicity with One and / or Two Immunizations.. https://www.usaspending.gov/award/CONT_AWD_75N93019C00060_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/versatope-therapeutics-inc-vsmpm3egyya6.